CO4370020A1 - PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE - Google Patents

PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE

Info

Publication number
CO4370020A1
CO4370020A1 CO95016013A CO95016013A CO4370020A1 CO 4370020 A1 CO4370020 A1 CO 4370020A1 CO 95016013 A CO95016013 A CO 95016013A CO 95016013 A CO95016013 A CO 95016013A CO 4370020 A1 CO4370020 A1 CO 4370020A1
Authority
CO
Colombia
Prior art keywords
formula
compound
preparation
alcoxy
chlorine
Prior art date
Application number
CO95016013A
Other languages
Spanish (es)
Inventor
Dales John Robert Mansfield
Original Assignee
Smithkline Beecham Plc
Smithkline Beechan P L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beechan P L C filed Critical Smithkline Beecham Plc
Priority to CO95016013A priority Critical patent/CO4370020A1/en
Publication of CO4370020A1 publication Critical patent/CO4370020A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE UN COMPUESTO DE LA FORMULA (A): FIGURA 1 DONDE X ES HIDROGENO, HIDROXIO, CLORO, C1-6 AL- COXIO O FENIL C1-6 ALCOXIO; Y Ra Y Rb SON HIDROGE- NO O ACILO O SUS DERIVADOS DE FOSFATO, CUYO PRO- CESO COMPRENDE: (i) LA PREPARACION DE UN COMPUESTO DE LA FORMULA (I): FIGURA 2 DONDE R1 ES C1-6 ALQUILO, O FENIL C1-6 ALQUILO DONDE EL GRUPO DE FENIL ES SUSTITUIDO OPCIONALMEN- TE; R2 ES HIDROGENO HIDROXIO, CLORINA, C1-6 AL- COXIO, FENIL C1-6 ALQUILSULFONILO, ACIDO, UN GRUPO AMINO O UN GRUPO DE AMINO PROTEGIDO, CUYA PREPARA- CION COMPRENDE LA REACCION DE UN COMPUESTO DE LA FORMULA (II): FIGURA 3 DONDE R2 Y R3 SON SEGUN SE DEFINE PARA LA FORMULA (I) CON: UN COMPUESTO DE LA FORMULA (V): FIGURA 4 DONDE L ES UN GRUPO SALIENTE Y R1 ES SEGUN SE DE- FINE EN LA FORMULA (I) PARA DAR UN COMPUESTO DE LA FORMULA (VI): FIGURA 5 Y DE ALLI EN ADELANTE CONVIERTE EL COMPUESTO IN- TERMEDIO DE LA FORMULA (VI) A UN COMPUESTO DE LA FORMULA (I) A TRAVES DESCARBOXILACION, Y SEGUN SEA NECESARIO O ACONSEJABLE, CONVIRTIENDO ENTRE SI LAS VARIABLES R1, R2 Y R3 A OTROS VALORES DE R1, R2 Y R3; (ii) LA CONVERSION DEL COMPUESTO RESULTANTE DE LA FORMULA (I) A UN COMPUESTO DE FORMULA (A) MEDIANTE LA CONVERSION DE LA VARIABLE R3, A AMINO, REDU- CIENDO LOS GRUPOS DE ESTERES C02R1 A CH2OH Y OP- CIONALMENTE, FORMANDO ACILO O SUS DERIVADOS DE FOSFATO, Y SEGUN SEA NECESARIO O ACONSEJABLE, CON- VIRTIENDO LA VARIABLE R2 EN EL COMPUESTO DE LA FORMULA (I) A LA VARIABLE X EN EL COMPUESTO DE LA FORMULA (A); CARACTERIZADO EN EL SENTIDO DE QUE: R2 ES CLORO EN LA FORMULA (I).A PROCESS FOR THE PREPARATION OF A COMPOUND OF FORMULA (A): FIGURE 1 WHERE X IS HYDROGEN, HYDROXY, CHLORINE, C1-6 ALCOXY OR PHENYL C1-6 ALCOXY; AND Ra AND Rb ARE HYDROGEN- OR ACIL OR ITS DERIVATIVES OF PHOSPHATE, WHOSE PROCESS INCLUDES: (i) THE PREPARATION OF A COMPOUND OF FORMULA (I): FIGURE 2 WHERE R1 IS C1-6 ALKYL, OR PHENYL C1 -6 RENT WHERE THE FENIL GROUP IS OPTIONALLY REPLACED; R2 IS HYDROGEN HYDROXY, CHLORINE, C1-6 ALCOXY, PHENYL C1-6 ALKYL SULPHONYL, ACID, AN AMINO GROUP OR A PROTECTED AMINO GROUP, WHOSE PREPARATION INCLUDES THE REACTION OF A COMPOUND OF THE FORMULA (II) 3 WHERE R2 AND R3 ARE AS DEFINED FOR FORMULA (I) WITH: A COMPOUND OF FORMULA (V): FIGURE 4 WHERE L IS AN OUTGOING GROUP AND R1 IS AS DEFINED IN FORMULA (I) TO GIVE A COMPOUND OF FORMULA (VI): FIGURE 5 AND THEREFORE CONVERTS THE INTERMEDIATE COMPOUND OF FORMULA (VI) TO A COMPOUND OF FORMULA (I) THROUGH DECARBOXYLATION, AND AS NECESSARY OR ADVISABLE, BECOMING BECOMING IF THE VARIABLES R1, R2 AND R3 TO OTHER VALUES OF R1, R2 AND R3; (ii) THE CONVERSION OF THE RESULTING COMPOUND FROM FORMULA (I) TO A COMPOUND OF FORMULA (A) THROUGH THE CONVERSION OF VARIABLE R3, TO AMINO, REDUCING THE GROUPS OF ESTERS C02R1 TO CH2OH AND OPTIONALLY FORMING ACIL OR ITS DERIVATIVES OF PHOSPHATE, AND AS NECESSARY OR ADVISABLE, CONVERTING THE VARIABLE R2 IN THE COMPOUND OF FORMULA (I) TO THE VARIABLE X IN THE COMPOUND OF FORMULA (A); CHARACTERIZED IN THE SENSE THAT: R2 IS CHLORINE IN THE FORMULA (I).

CO95016013A 1995-04-19 1995-04-19 PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE CO4370020A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO95016013A CO4370020A1 (en) 1995-04-19 1995-04-19 PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO95016013A CO4370020A1 (en) 1995-04-19 1995-04-19 PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE

Publications (1)

Publication Number Publication Date
CO4370020A1 true CO4370020A1 (en) 1996-10-07

Family

ID=40909583

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95016013A CO4370020A1 (en) 1995-04-19 1995-04-19 PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE

Country Status (1)

Country Link
CO (1) CO4370020A1 (en)

Similar Documents

Publication Publication Date Title
ES8504194A1 (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent.
DE69018529D1 (en) Phospholipase A2 inhibitor, microorganisms that produce this inhibitor and several methods for its production.
AR241183A1 (en) Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido{1,2,3-de]{1, 4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4- dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carb
ES2101319T3 (en) ANALOGS OF VITAMIN D.
KR840006483A (en) Method for preparing an antiviral compound
MY128846A (en) Preparation of purines
ES8801377A1 (en) Process for producing D-alpha-amino acids.
ATE18054T1 (en) DERIVATIVES AND REDUCTION PRODUCTS OF DGLUCOPYRANOSYL-ALPHA(1-5)-D-ARABONIC ACID, THEIR PRODUCTION AND USE.
EP0152965A3 (en) Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxy-menthyl)-purines and certain derivatives
MX173028B (en) METHOD FOR PREPARING A COMPOSITION OF MONOTIOPHOSPHORIC ACID DIHIDROCARBIL
CO4370020A1 (en) PROCESS FOR THE PREPARATION OF ANTIVIRAL AGENTS DERIVED FROM PURINE
HU906228D0 (en) New process for the production of 9-(2,2-di)alkoxi-carbonyl)-cyclopropyl)-purine derivatives
HU9302706D0 (en) Process for producing 5-oxo-dibenzo[a,d]cyclohepta-1,4-diene derivatives
DE3370331D1 (en) Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents
ES2104177T3 (en) NOVEL ANALOGS OF VITAMIN D.
ATE141250T1 (en) METHOD FOR PRODUCING SUBSTITUTED INDANONES
ATE144795T1 (en) ENZYMATIC ASYMETRIC REDUCTION PROCESS FOR PRODUCING 4H THIENO (2,3-6) THIOPYRENE DERIVATIVES.
ATE135340T1 (en) METHOD FOR PRODUCING SUBSTITUTED INDANONES
ES8406507A1 (en) Hexanor-brassinolid-22-ethers
HUT37116A (en) Process for production of phenil-alanin derivatives
IT1277339B1 (en) PROCESS FOR THE PRODUCTION OF IODURATED CONTRASTING AGENTS
ES8301931A1 (en) Imidazoles.
ES8100304A1 (en) Process for producing eburnane derivatives
MX9203701A (en) BETA-CARBOLIN-3-CARBONIC ACID ESTERS 5 or 6 SUBSTITUTED.
GB8907008D0 (en) Intermediates useful for the synthesis for delphinidin chloride